[Occurrence and therapy of drug exanthemas].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000700:Analgesics / Q000009:adverse effects; D001604:Berlin; D002648:Child; D002675:Child, Preschool; D003875:Drug Eruptions / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D004892:Erythema Multiforme / Q000139:chemically induced / Q000188:drug therapy; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007902:Length of Stay; D008875:Middle Aged; D010406:Penicillins / Q000009:adverse effects; D011241:Prednisone / Q000627:therapeutic use; D013449:Sulfonamides / Q000009:adverse effects; D014581:Urticaria / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*
D000700:Analgesics; D006634:Histamine H1 Antagonists; D010406:Penicillins; D013449:Sulfonamides; D011241:Prednisone
Häufigkeit und Therapie der Arzneimittelexantheme.